CD8A and neoplasm: Total cell counts across whole tumor sections were performed to determine immune-to-tumor cell ratio; CD8+, CD4+, and CD20+ lymphocytes increased 10-fold, 3-fold, and 2-fold, respectively, in the SC mts with respect to the primary tumor, while Foxp3+ cells were scarce (Figure 2B).